BioSpace News Archive

Reflect Scientific, Inc. (Symbol:RSCF), a provider of diverse products and services for the biotechnology, pharmaceutical and transportation industries announces continued strong year over year revenue gains of 243%.

Enteris BioPharma, Inc. , a biotechnology company developing innovative drug products built around its proprietary delivery technologies and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), announced that the company will host a webinar featuring John Vrettos , Ph.D., Senior Principal Scientist and Head of

US FDA approves +PLUSPAK™ (polymer bottle) Pharmacy Bulk Package for the gadolinium-based contrast agent, Clariscan™ (gadoterate meglumine) As the only polymer bottle for an MRI contrast agent, Clariscan in +PLUSPAK offers the potential for increased workplace safety, efficiency, convenience and environmental advantages Clariscan has been approved in more than 65 countries globally, with more than six million patient doses shipped

GB1211, a potent oral small molecule galectin-3 inhibitor was well tolerated in Phase 1 studies Phase 2a study planned to establish the anti-fibrotic effects of GB1211 in grade 2 to 4 Non-Alcoholic SteatoHepatitis (NASH) Data presented at the American Chemical Society Meeting, Drug Discovery Chemistry and EFMC-ISMC BOSTON and COPENHAGEN, Denmark, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Galecto, Inc., a privately-held biotechnology company focused on the development of novel treatme

iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced compelling data supporting ProFound AI™ Risk was published in the peer-reviewed journal, Radiology.

Molecular diagnostics company Genetic Technologies Limited (ASX: GTG, NASDAQ:GENE) (“Genetic Technologies” or the “Company”) is developing a Polygenic Risk Score (PRS) test for COVID-19 which may enable an assessment of risk of an individual developing a serious disease should they contract the virus.

Cerapedics, a private ortho-biologics company, today announced the Health Canada approval of the company’s next-generation bone graft called i-FACTOR+ Matrix, making it the first market to approve the commercial launch of this product.

Mail service pharmacy is swiftly becoming a highly used channel of distribution of pharmaceutical products to the consumers.

Fertility tracking apps are mobile phone applications that help women keep track of their menstrual cycles on a regular basis, to enhance their ability to plan their motherhood, among other uses.

American Lung Association releases ‘The Road to Clean Air’ report detailing benefits of transition to electric transportation